Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

4.52
-0.1155-2.49%
Volume:14.05M
Turnover:64.00M
Market Cap:1.84B
PE:-2.49
High:4.75
Open:4.66
Low:4.47
Close:4.64
Loading ...

Stock Track | Recursion Pharmaceuticals (RXRX) Surges 6.93% in Pre-market: AI-Driven Drug Discovery Attracts Investor Interest

Stock Track
·
12 May

Should You Buy This Beaten-Down Artificial Intelligence (AI) Stock on the Dip?

Motley Fool
·
12 May

Why Recursion Pharmaceuticals Stock Plummeted 24% This Week

Motley Fool
·
10 May

Stock Track | Recursion Pharmaceuticals (RXRX) Soars 5.17% Pre-market Amid Medical AI Sector Strength

Stock Track
·
07 May

Hold Rating for Recursion Pharmaceuticals Amid Program Discontinuations and Financial Concerns

TIPRANKS
·
07 May

24H|Crypto Shares Gain; Canaan up 10%; Riot Platforms up 5%; Medical AI Stocks Rise; RXRX up 4%; Gold Shares Fall

Tiger Newspress
·
07 May

Why Recursion Pharmaceuticals Stock Is Plummeting Today

Motley Fool
·
07 May

Stock Track | Recursion Pharmaceuticals (RXRX) Plummets 5.15% as Analysts Slash Price Targets

Stock Track
·
06 May

Recursion Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $8 From $10

THOMSON REUTERS
·
06 May

Cautious Outlook on Recursion Pharmaceuticals Amid Strategic Shifts and Early-Stage Developments

TIPRANKS
·
06 May

Recursion Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
06 May

Recursion Pharmaceuticals (RXRX) Receives a Hold from TD Cowen

TIPRANKS
·
06 May

Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ), Recursion Pharmaceuticals (RXRX) and Cardinal Health (CAH)

TIPRANKS
·
06 May

Recursion Pharmaceuticals (NasdaqGS:RXRX) Reports Q1 Sales Increase and REC-4881 Trial Results

Simply Wall St.
·
06 May

Shares of Recursion Pharmaceuticals Slide After 1Q Loss

Dow Jones
·
06 May

Recursion Pharmaceuticals Shares Fall 3.9% Premarket After Q1 Results

THOMSON REUTERS
·
05 May

Recursion Pharmaceuticals Q1 Loss Widens, Revenue Increases

MT Newswires Live
·
05 May

Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Revenue $14.7M, vs. FactSet Est of $15M

MT Newswires Live
·
05 May

Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Net Loss $0.50 a Share, vs. FactSet Est of $0.39 Loss

MT Newswires Live
·
05 May

Recursion Pharmaceuticals Q1 EPS USD -0.5

THOMSON REUTERS
·
05 May